• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1 Back to Search Results
Model Number 801763
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Neurological Deficit/Dysfunction (1982)
Event Date 08/02/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).As of (b)(6) 2016, the patient is still in icu.The hospital asked the local terumo fsr to check out this system-1 as a precaution.The fsr visited the user facility and gathered the data logs for further evaluation.He was unable to duplicate any problems with the system-1.The fsr cleaned dry blood from the air bubble detector.The unit operated to manufacturer specifications and was returned to clinical use.Per the data log review, most of the module/pump logs cover that date and there is no indication of a problem in those logs.The system log only goes back to (b)(6) 2016 due to the logging issue and does not cover the date in question.There is no indication of a problem with the system in the logs.No parts or device will be returned to the manufacturer for evaluation.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Event Description
The customer called to have field service perform a system check on the perfusion system and capture data logs, no alleged deficiency.The issue occurred during use of the device for a cardiopulmonary bypass (cpb).The device was not changed out.The surgical procedure was completed as scheduled.There was no delay and no blood loss.Per the clinical review on 31-aug-2016: manufacturer clinical services (cs) spoke to the perfusionist (ccp) on the case in regards to this procedure and he provided these details.The actual surgical procedure was (b)(6) 2016.Though the procedure coronary artery bypass graft (cabg x3) was completed as scheduled and without known technical or clinical issues, the patient was "slow" to awake post surgery in the intensive care unit (icu).According to the ccp, a centrifugal pump was used as the arterial pump and he used all the available safety systems, including: an air bubble detector, level sensors, and line pressure monitoring.The ccp stated no active alarms occurred during the procedure and no air was ever observed in main sections of the cpb circuit.The ccp stated the venous oxygen saturation (svo2) was in normal range during cpb with no levels less than 72%.Cerebral oximetry was used and no issues were observed and cerebral oxygen saturations were adequate and at expected levels.The patient was weaned from cpb without issues and transferred to icu per normal practice.Neurologic dysfunction was observed later in the icu, but again there was no indication or mention of a malfunction of the system-1 and/or perfusion circuit.This system-1 was used multiple times after this procedure on (b)(6) 2016.This hospital had a patient injury event during cpb in (b)(6) 2014.As a system-1 (not this system) was used on that earlier procedure, and risk management became aware of this recent patient, the hospital asked the local field service representative (fsr) to check out this system-1 as a precaution.The manufacturer was informed of this incident on 26-aug- 2016.The system was inspected and no functional issues were found.The procedure on (b)(6) 2016 was completed as scheduled, with no delay and no associated blood loss.The patient did have a serious injury post surgery, but there is no indication of any malfunctions of the system-1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO ADVANCED PERFUSION SYSTEM 1
Type of Device
CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS-ADVANCED PERFUSION SYSTEM 1
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORP.
6200 jackson road
ann arbor MI 48103
Manufacturer Contact
jan winder
6200 jackson road
ann arbor, MI 48103
7346634145
MDR Report Key5962726
MDR Text Key55114654
Report Number1828100-2016-00629
Device Sequence Number1
Product Code DTQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K022947
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other
Type of Report Initial
Report Date 09/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number801763
Device Catalogue Number801763
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/26/2016
Initial Date FDA Received09/20/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/19/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-